Search Our Scientific Publications & Authors

Publications
find publications by category +
Translate page:

Interventional oncology procedures for breast cancer metastatic disease: current role and clinical applications.

Authors:
Dimitrios K Filippiadis Evgenia Efthymiou Konstantinos Palialexis Elias Brountzos Nikolaos Kelekis

Diagn Interv Radiol 2022 May;28(3):249-256

2nd Department of Radiology, University General Hospital "Attikon", Medical School, National and Kapodistrian University of Athens, Athens, Greece.

Worldwide, breast cancer constitutes the most common malignant neoplasm among females, impacting 2.1 million women annually. Interventional oncology techniques have been recently added as an additional therapeutic and palliative alternative in breast cancer metastatic disease, concerning mainly osseous, liver, and lung metastasis. In the current literature, there are reports of promising results and documented efficacy regarding the ablation of liver and lung metastasis from breast carcinoma, transarterial embolization or radioembolization, as well as the treatment of osseous metastatic disease. These literature studies are limited by the heterogeneity of breast cancer disease, the evaluation of variable different parameters, as well as the retrospective nature in most of the cases. Consequently, dedicated prospective series and randomized studies are required to identify the role of minimally invasive local therapies of interventional oncology armamentarium. The present review paper focuses upon the current role of interventional oncology techniques for the curative or palliative treatment of metastatic breast cancer disease. The purpose of this review paper is to present the current minimally invasive procedures in the treatment of metastatic breast disease, including local control rates and survival rates.

Download full-text PDF

 Source
http://dx.doi.org/10.5152/dir.2022.20911DOI Listing
May 2022

Publication Analysis

Top Keywords

breast cancer
20
interventional oncology
16
metastatic disease
12
review paper
8
liver lung
8
treatment metastatic
8
metastatic breast
8
oncology techniques
8
lung metastasis
8
current role
8
cancer disease
8
minimally invasive
8
cancer metastatic
8
breast
7
disease
6
metastatic
5
cancer
5
cases consequently
4
nature cases
4
retrospective nature
4

Keyword Occurance

Similar Publications

Clinical evaluation of the first domestically produced generic isosulfan blue injection in sentinel lymph node biopsy for early breast cancer in China: A multicenter, single-arm, open validation trial (CSBrS-024).

Authors:
Fengjiang Qu Di Wu Yunjiang Liu Wei Gao Shu Wang Siyuan Wang Feng Jin Bo Chen Jian Huang Shanshan Sun Zhimin Fan

Chin Med J (Engl) 2022 Aug 12. Epub 2022 Aug 12.

Breast Surgery Department, General Surgery Center, The First Hospital of Jilin University, Changchun, Jlilin 130021, China.

View Article and Full-Text PDF
August 2022
Similar Publications

Radiologist preferences for artificial intelligence-based decision support during screening mammography interpretation.

Authors:
Nathaniel Hendrix Kathryn P Lowry Joann G Elmore William Lotter Gregory Sorensen William Hsu Geraldine J Liao Sana Parsian Suzanne Kolb Arash Naeim Christoph I Lee

J Am Coll Radiol 2022 Aug 12. Epub 2022 Aug 12.

Department of Radiology, University of Washington, Seattle Cancer Care Alliance, Seattle, Washington; Department of Health Services, School of Public Health, University of Washington, Seattle, Washington; Deputy Editor, Journal of the American College of Radiology.

Background: Artificial intelligence (AI) may improve cancer detection and risk prediction during mammography screening, but radiologists' preferences regarding its characteristics and implementation are unknown.

Purpose: To quantify how different attributes of AI-based cancer detection and risk prediction tools affect radiologists' intentions to use AI during screening mammography interpretation.

Materials And Methods: Through qualitative interviews with radiologists, we identified five primary attributes for AI-based breast cancer detection and four for breast cancer risk prediction. Read More

View Article and Full-Text PDF
August 2022
Similar Publications

Misalignment of Values Associated with Radiology Staff Burnout.

Authors:
Jay R Parikh Katelyn J Cavanaugh Courtney L Holladay

J Am Coll Radiol 2022 Aug 12. Epub 2022 Aug 12.

Associate Vice President, Leadership Institute, The University of Texas MD Anderson Cancer Center, 7007 Bertner Avenue, Houston, TX, USA.

View Article and Full-Text PDF
August 2022
Similar Publications

Therapeutic efficacy of Nano-formulation of lactoperoxidase and lactoferrin via promoting immunomodulatory and apoptotic effects.

Authors:
Esmail M El Fakharany Mahmoud Ashry Abd-Elaleem H Abd-Elaleem Mahmoud H Romeih Fatma Adly Morsy Reem A Shaban Khaled G Abdel-Wahhab

Int J Biol Macromol 2022 Aug 12. Epub 2022 Aug 12.

Medical Physiology Department, National Research Centre, Giza, Egypt. Electronic address:

This study identifies promising potential of a novel and safer nanocombination of bovine milk lactoperoxidase (LPO) and lactoferrin (LF) to target breast cancer in vitro and in adult female albino rat model. Favorable selective anticancer effects of the prepared nanocombination were observed, in a dose-dependent manner, against both MCF-7 and MDA cell lines, sparing normal HFB-4 cells. The administration of LPO + LFNPs markedly improved the induced-breast cancer disorders, prolonged survival and reduced the values of serum TNF-α, IL1β, CD4, ALAT, ASAT, urea, creatinine, cholesterol and triglycerides with remarkable elevation in mammary SOD and GPx activity and GSH level. Read More

View Article and Full-Text PDF
August 2022
Similar Publications

[Metabolic syndrome and cancer risk].

Authors:
Hans Scherübl

Dtsch Med Wochenschr 2022 Aug 15;147(16):1068-1077. Epub 2022 Aug 15.

Cancer has become a leading cause of death among patients with metabolic syndrome (MetS). The more components of MetS a patient has, the higher his risk of cancer. MetS is causally associated with colorectal, pancreatic, gallbladder, biliary, hepatocellular, gastric, esophageal, thyroid, breast, endometrial and renal cell cancers. Read More

View Article and Full-Text PDF
August 2022
Similar Publications
}